Chartered Statistician, Royal Statistical Society, UK.

Ph.D. in Statistics, Department of Statistics, University of Glasgow.

Postgraduate module in Teaching, Learning and Assessment in Higher Education, Teaching and Learning Service, University of Glasgow.

Master in Science (Mathematics and Statistics) First Class Honours, University of Glasgow.

Council of Vice Chancellors and Principals Overseas Research Scholarship, Committee of Vice-Chancellors and Principals, U.K., 1999.

University of Glasgow Postgraduate Scholarship, University of Glasgow, 1999.

Most Outstanding Statistics Graduate at University of Glasgow, William M. Mercer Ltd, 1999.

Associate Editor for Trials, 2020.

NCRI Head & Neck Study Group, Appointed Member, National Cancer Research Institute (NCRI), 2016-present.

NCRI Skin Cancer Study Group, Appointed Member, National Cancer Research Institute (NCRI), 2017-present.

TMRP Stratified Medicine Working Group, Joint Lead, MRC-NIHR Trials Methodology Research Partnership, 2019-present.

TMRP Adaptive Design Working Group, Member, MRC-NIHR Trials Methodology Research Partnership (TMRP), 2013-present.

NIHR Early Phase Clinical Trials, Co-Chair (from 2019), Committee Member (2015-2019), NIHR Statistics Group, 2015-present.

RDS West Midlands, Statistical Advisor, RDS West Midlands, 2015-2019.

Cancer Research UK Clinical Expert Review Panel (CERP), Co-opted funding panel member, Cancer Research UK Clinical Expert Review Panel (CERP), 2018-2019.

MRC Experimental Medicine Panel, Full funding panel member (from 2021); Interim member (2020), Medical Research Council (MRC) Experimental Medicine, 2020-present.

Rare Disease subgroup (TMRP Stratified Medicine Working Group), Lead, MRC-NIHR Trials Methodology Research Partnership (TMRP), Jan 2020-present.

ESMO Targeted Anticancer Therapies Congress, Congress Scientific Committee member, ESMO, 2020-2021.

Athena SWAN, Steering Group member (Co-chair from 2021), ICR, 2020-present.

TMRP Statistical Analysis Working Group, Core Committee member, MRC-NIHR Trials Methodology Reserach Partnership, 2019-present.

Cancer Research UK Clinical Research Committee, Funding panel member, Cancer Research UK, 2018-present.

Scientific Evaluation Committee, Member on "early phase clinical trials of innovative drugs", French National Cancer Institute (INCa), 2021-present.